418 related articles for article (PubMed ID: 34659214)
1. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
Li A; Guo F; Pan Q; Chen S; Chen J; Liu HF; Pan Q
Front Immunol; 2021; 12():728190. PubMed ID: 34659214
[TBL] [Abstract][Full Text] [Related]
2. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
3. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.
Yang C; Sun J; Tian Y; Li H; Zhang L; Yang J; Wang J; Zhang J; Yan S; Xu D
Front Immunol; 2021; 12():714832. PubMed ID: 34603289
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N
Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923
[TBL] [Abstract][Full Text] [Related]
6. Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus.
Geng L; Tang X; Wang S; Sun Y; Wang D; Tsao BP; Feng X; Sun L
Front Immunol; 2020; 11():233. PubMed ID: 32133007
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
Radmanesh F; Mahmoudi M; Yazdanpanah E; Keyvani V; Kia N; Nikpoor AR; Zafari P; Esmaeili SA
IUBMB Life; 2020 Nov; 72(11):2366-2381. PubMed ID: 33006813
[TBL] [Abstract][Full Text] [Related]
8. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
[TBL] [Abstract][Full Text] [Related]
9. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus.
Tang WY; Liu JH; Peng CJ; Liao Y; Luo JS; Sun X; Tang YL; Luo XQ
Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):7. PubMed ID: 33713197
[TBL] [Abstract][Full Text] [Related]
10. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
Zhu Y; Feng X
Stem Cell Res Ther; 2018 May; 9(1):149. PubMed ID: 29793537
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
Liu S; Guo YL; Yang JY; Wang W; Xu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
[TBL] [Abstract][Full Text] [Related]
13. A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus.
Wang D; Feng X; Lu L; Konkel JE; Zhang H; Chen Z; Li X; Gao X; Lu L; Shi S; Chen W; Sun L
Arthritis Rheumatol; 2014 Aug; 66(8):2234-45. PubMed ID: 24756936
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell exosomal tsRNA-21109 alleviate systemic lupus erythematosus by inhibiting macrophage M1 polarization.
Dou R; Zhang X; Xu X; Wang P; Yan B
Mol Immunol; 2021 Nov; 139():106-114. PubMed ID: 34464838
[TBL] [Abstract][Full Text] [Related]
15. Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.
Zhang H; Zeng X; Sun L
Expert Opin Biol Ther; 2010 May; 10(5):701-9. PubMed ID: 20345339
[TBL] [Abstract][Full Text] [Related]
16. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2.
Zhang Z; Huang S; Wu S; Qi J; Li W; Liu S; Cong Y; Chen H; Lu L; Shi S; Wang D; Chen W; Sun L
EBioMedicine; 2019 Jul; 45():341-350. PubMed ID: 31248835
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder.
Fathollahi A; Gabalou NB; Aslani S
Lupus; 2018 Jun; 27(7):1053-1064. PubMed ID: 29631514
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
Xu J
Adv Exp Med Biol; 2018; 1089():73-85. PubMed ID: 29767288
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
[TBL] [Abstract][Full Text] [Related]
20. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L
Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
